He has developed paradigms that are being used to screen drugs that enhance social function, and is developing novel strategies for drug discovery for
treating social impairments in autism and schizophrenia.
Not exact matches
The study, which appears in Biological Psychiatry, suggests that
social impairments characteristic of autism spectrum disorder may stem from alteration of activity in this circuit, and that tuning this circuit may help
treat the
social deficits in the disorder.
The tool could pave the way for early interventions that prevent and
treat a range of physical, psychological,
social, and cognitive
impairments.
Attention - deficit hyperactivity disorder (ADHD) affects 3 % — 5 % of children and young people under 18 years old.1 The core symptoms include inattention, impulsivity and hyperactivity leading to significant
impairments in academic and
social function and increased risk of substance misuse, unemployment, criminality and mental health problems.2 3 Early treatment is crucial to improve symptoms and reduce the burden on the family and wider
social and healthcare systems.4 With the increasing rates of diagnosis of ADHD, spending on ADHD medication has increased sevenfold between 1998 and 2005,5 and expenditure on medication treatment costs in the UK is now estimated at # 78 million per year.5 6 This has placed increasing financial burden on health services and highlighted the need for more efficient and cost - effective services to diagnose and
treat the condition.